IMUGENE LIMITED

1.35%

37.5¢

Market Cap $82.39M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

IMU

Media Thread

303 304 305

19/07/25

18K

8.8M

19/07/25

Last post Raffout

18K

8.8M

IMU

Ann: Change of Director's Interest Notice x 3

19/07/25

6.6K

19/07/25

Last post alcar

6.6K

IMU

Why IMU is a multi multi bagger

529 530 531

19/07/25

31K

16M

19/07/25

Last post iluminaughty

31K

16M

IMU

New, temporarily, code IMUDA

5 6 7

19/07/25

376

138K

19/07/25

Last post Jeffhh

376

138K

IMU

IMU: Big Dreams, Tough Lessons and Yep… Another Thread No One Asked For

19/07/25

17K

19/07/25

Last post alcar

17K

IMU

Ann: Imugene Completes $22.5M Placement and c.$15M SPP

18/07/25

13K

18/07/25

Last post timbuckley

13K

IMU

Ann: Azer-cel new data Webinar

2 3 4

18/07/25

185

51K

18/07/25

Last post timbuckley

185

51K

IMU

Ann: Trading Halt

3 4 5

18/07/25

282

93K

18/07/25

Last post farmhouse

282

93K

See All Discussions

Timeline

Change of Director's Interest Notice x 3
18 Jul 16:22	Share

Application for quotation of securities - IMU
16 Jul 16:20	Share

Azer-cel new data Webinar
16 Jul 12:45	Share

Prospectus
16 Jul 10:57	Share

Imugene Capital Raising Presentation
16 Jul 10:40	Share

Proposed issue of securities - IMU
16 Jul 10:39	Share

Proposed issue of securities - IMU
16 Jul 10:36	Share

Imugene Completes $22.5M Placement and c.$15M SPP
16 Jul 10:36	Share

Trading Halt
14 Jul 08:56	Share

Two Additional Complete Responses in azer-cel Ph1b trial
14 Jul 08:34	Share

Imugene Receives $5.8m R&D Tax Refund
04 Jul 09:42	Share

1st Patient Dosed in Australia PD1-Vaxx neo-POLEM PhII Trial
27 Jun 09:30	Share

Results of Meeting
26 Jun 11:19	Share

EGM Presentation
26 Jun 10:22	Share

US patent allowance for onCARlytics
18 Jun 09:18	Share

Notification of cessation of securities - IMU
06 Jun 16:22	Share

1st Australian site activated PD1-Vaxx Neo-POLEM Ph II trial
02 Jun 09:12	Share

Dr John Byon appointed Chief Medical Officer
30 May 09:57	Share

Consolidation/Split - IMU
29 May 10:16	Share

Letter to Imugene Shareholders
28 May 09:33	Share

Addendum to Notice of Extraordinary General Meeting
27 May 18:12	Share

Notice of Extraordinary General Meeting/Proxy Form
27 May 12:47	Share

Notification regarding unquoted securities - IMU
23 May 16:11	Share

Notification of cessation of securities - IMU
21 May 16:42	Share

Proposed Consolidation of Capital
16 May 12:56	Share

Letter to Shareholders
01 May 11:59	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:47	Share

Application for quotation of securities - IMU
14 Apr 16:45	Share

Notification of cessation of securities - IMU
11 Apr 16:55	Share

Notification regarding unquoted securities - IMU
11 Apr 16:50	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 37.5¢		Change 0.005(1.35%)		Mkt cap ! $82.39M

Open	High	Low	Value	Volume
37.0¢	37.5¢	36.0¢	$342.2K	938.4K

Buyers (Bids)

No.	Vol.	Price($)
1	488	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
37.5¢	12566	2

View Market Depth

No.	Vol.	Price($)
4	64143	0.365
8	258148	0.360
7	134035	0.355
16	165231	0.350
6	198970	0.345

Price($)	Vol.	No.
0.375	12566	2
0.380	21000	2
0.385	17121	3
0.390	17530	3
0.395	222522	6

Last trade - 16.10pm 18/07/2025 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED

Corporate Spotlight
Not Yet Available

Latest Threads

Military metal stocks with US projects are running ...

Timeline

Featured News

Latest Videos

Imugene (ASX:IMU) doses first patients in VAXINIA combination study

03 Mar 2023 14:39 (AEDT)

Imugene (ASX:IMU) receives US patent for PD1-Vaxx

10 Feb 2023 10:58 (AEDT)

Imugene (ASX:IMU) advances VAXINIA trial

02 Feb 2023 12:21 (AEDT)

Latest Articles

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

The ASX has headed into a downturn this Wednesday, mostly thanks to U.S. CPI data from June suggesting Trump’s tariffs are finally having an impact on inflation, but that hasn’t stopped several companies flying on the forums.Listen to the HotCopper podcast for in-d...

Yes, we burn a lot of cash: Imugene issues letter to investors as 1Y returns -72%

As it clocks one year returns down -72%, Imugene Ltd (ASX:IMU) this week issued a letter to shareholders confirming shareholders'...

First Aussie doses bring Imugene major step closer to 'quicker, cheaper' non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic CAR T-cell therapy Azer-cel treatment at the Royal Prince Alfred Hospital in Sydney earlier this week.This dosage marks the start of Imugene’s Phase 1b t...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

IMUGENE LIMITED

Corporate SpotlightNot Yet Available

Latest Threads

Military metal stocks with US projects are running ...

Timeline

Featured News

Latest Videos

Imugene (ASX:IMU) doses first patients in VAXINIA combination study

03 Mar 2023 14:39 (AEDT)

Imugene (ASX:IMU) receives US patent for PD1-Vaxx

10 Feb 2023 10:58 (AEDT)

Imugene (ASX:IMU) advances VAXINIA trial

02 Feb 2023 12:21 (AEDT)

Latest Articles

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

The ASX has headed into a downturn this Wednesday, mostly thanks to U.S. CPI data from June suggesting Trump’s tariffs are finally having an impact on inflation, but that hasn’t stopped several companies flying on the forums.Listen to the HotCopper podcast for in-d...

Yes, we burn a lot of cash: Imugene issues letter to investors as 1Y returns -72%

As it clocks one year returns down -72%, Imugene Ltd (ASX:IMU) this week issued a letter to shareholders confirming shareholders'...

First Aussie doses bring Imugene major step closer to 'quicker, cheaper' non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic CAR T-cell therapy Azer-cel treatment at the Royal Prince Alfred Hospital in Sydney earlier this week.This dosage marks the start of Imugene’s Phase 1b t...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available